Cloud Hosting

MCI Onehealth Partners with MDClone to Accelerate Research through Global Clinical Intelligence Offering

By granting global partners access to real-world insights and synthetic data, the new partnership aims to accelerate research and inspire new therapy development to drive better patient outcomes

TORONTO, July 28, 2022 (GLOBE NEWSWIRE) --MCI Onehealth Technologies Inc. (MCI) (TSX: DRDR), a clinician-led healthcare technology company focused on increasing access to and quality of healthcare, andMDClone, a digital health company and leader in synthetic data, are pleased to announce an advanced clinical intelligence offering for their global partners. This offering combines real-world health insights with mirrored synthetic data to power deeper research and inspire novel therapeutic development.

MCIs collaboration with MDClone will provide our partners with greater access to high-valuedata-insights-as-a-servicefor an array of research, clinical and data science needs, saidDr.Alexander Dobranowski, MD, Chief Executive Officer of MCI. Whether through MCIs clinic network, international healthcare providers, or pharmaceutical, life sciences and biotech partners, our mutually enhanced insights will help to quickly translate healthcare data and research into improved health and quality of life for patients.

The real-world patient health journeys that MCIs tech-enabled network is able to capture offer a comprehensive picture to researchers, who can benefit from a fuller perspective. The partnership between MCI and MDClone will leverage MDClones technology to load, organize and protect MCI-generated patient data and use this data to help find insights to improve care. In addition, MCI and MDClone intend to work together to improve data collection and curation to better serve the needs of applied healthcare research.

MDClone offers clients robust, detailed data for thorough end-to-end, real-world analysis. Using the MDClone ADAMS Platform analytics tools and synthetic data capabilities, clinicians, researchers, and healthcare professionals can explore healthcare data more efficiently to accelerate real-world evidence processes. Withsynthetic data capabilitiesat the forefront, users can leverage self-service tools to access, analyze, and share information without privacy concerns. Additionally, the real-time identification and extraction of information about a specific population of interest allows users at healthcare systems to overcome some of the common barriers that can slow clinical data projects progress.

Were thrilled to partner with innovators like MCI in the healthcare and life science industries and beyond. Together, we can provide tailored clinical insights that meet clients needs, and from those insights, MDClone can generate synthetic data that researchers can use to better understand disease progression, enhance care delivery, and develop new products that can improve patient outcomes, saidJosh Rubel, Chief Operating Officer of MDClone.

In keeping with its objective to be a preeminent health technology leader, MCI nurtures international opportunities to leverage its vast pool of high-quality structured clinical information. The MDClone ADAMS Platforms unique ability to convert datasets and cohorts of interest intosynthetic filesthat are statistically comparable to the original data, but composed entirely of artificial patients, aids in broader and more secure access and opens the doors to third-party access and larger-scale research impact.

MCIs audience for health insights continues to grow in Canada and will further benefit from access to MDClones global roster of top-tier health system and pharma relationships. The collaboration with MDClone will accelerate MCIs entry into the clinical insights and analytics sectors in the United States of America and Israel, including potential access to headquarter-level decision-makers of global pharma and life science leaders.

Through this commercial arrangement, we each have the benefit of immediate introduction to the active client rosters of the other, and we each gain a superior andunique offering to acquire new partners, fueling the expansion of MCIs health insight services into international markets, added Dr. Dobranowski.

About MCI

MCI is a healthcare technology company focused on empowering patients and doctors with advanced technologies to increase access, improve quality, and reduce healthcare costs. As part of the healthcare community for over 30 years, MCI operates one of Canadas leading primary care networks with nearly 260 physicians and specialists, serves more than one million patients annually and had nearly 300,000 telehealth visits last year, including online visits viamciconnect.ca. MCI additionally offers an expanding suite of occupational health service offerings that support a growing list of nearly 600 corporate customers. Led by a proven management team of doctors and experienced executives, MCI remains focused on executing a strategy centered around acquiring technology and health services that complement the companys current roadmap. For more information, visitmcionehealth.com.

About MDClone

MDClone offers an innovative, self-service data analytics environment powering exploration, discovery, and collaboration throughout healthcare ecosystems cross-institutionally and globally. The powerful underlying infrastructure of theMDClone ADAMS Platformallows users to overcome common barriers in healthcare in order to organize, access, and protect the privacy of patient data while accelerating research, improving operations and quality, and driving innovation to deliver better patient outcomes. Founded in Israel in 2016, MDClone serves major health systems, payers, and life science customers in the United States, Canada, and Israel. Visitmdclone.comfor more information.

For media enquiries please contact:Nolan Reeds | MCI Onehealth | nolan@mcionehealth.comErin Giegling | MDClone | erin.giegling@mdclone.com

Read the original post:

MCI Onehealth Partners with MDClone to Accelerate Research through Global Clinical Intelligence Offering - Bio-IT World